RECRUITING Not applicable ClinicalTrials.gov

SuperCAP Program to Improve Cognition and Daily Functioning in Post-COVID-19 Condition

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • ClinicalTrials.gov ID: NCT07530757

Registry updated: 2026-09-11

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The goal of this study is to determine whether the SuperCAP intervention program is superior to control in reducing disability from baseline to the post-intervention assessment in people with Post-COVID-19 Condition. The main question it aims to answer is whether participants assigned to SuperCAP experience a greater reduction in disability, defined as an improvement of at least 5 points on the WHODAS 2.0 from baseline to the post-intervention visit, compared with participants in the control group. Participants assigned to the SuperCAP intervention will undergo a series of sessions that include psychoeducation, adaptive cognitive training exercises, fatigue self-management strategies, and multidisciplinary content.

Interventions

SuperCAP intervention program (Device)
The SuperCAP (Supervised Computerized Active Program) is an online, multidimensional therapeutic program integrated into eSalut, the Catalan Institute of Health's digital platform, designed to improve daily functioning and quality of life in individuals with PCC who experience cognitive symptoms
Psychoeducational intervention (Other)
The psychoeducational intervention is a non-pharmacological interventions that teach practical strategies to help individuals with the cognitive disorders and fatigue associated with long COVID and provide general guidelines on how to manage these symptoms so that they have the least possible impact on daily life.

Eligibility criteria

Inclusion Criteria: * Diagnosis of PCC, defined as the presence of three or more symptoms associated with COVID-19 infection for at least three months, not explained by other diseases. * Age 18 to 65 years. * Willingness to participate in an app-based intervention program aimed at improving daily Functioning in People Living with PCC. * Evidence of patient-reported cognitive difficulties emerging after COVID-19, operationalized as a WHODAS 2.0 Cognition Domain (D1) score \> 6 at baseline via RedCAP. * Digital proficiency defined as scoring ≥4 on MDPQ-16 item 2a (sending emails) and ≥3 on item 6a (using the device's app store) via RedCAP. * Self-reported ability to use a mobile application for approximately 15 minutes per day, 5 days per week, considering their current symptoms. * Possession of a personal smartphone compatible with the study mobile application (eSalut), with sufficient storage space and operating system version required for installation. Exclusion Criteria: * Inability to undergo neuropsychological tests or additional assessments. * Prior use of the SuperCAP program. * Current participation in a trial or program aimed at improving PCC symptoms. * Any condition that, in the investigator's opinion, could make participation unsafe, complicate interpretation of study results, interfere with achievement of study objectives, or otherwise affect the participant's ability to complete the study.

Conditions

Post COVID Condition

Locations

Fundació Lluita contra les Infeccions - Hospital Universitari Germans Trias i Pujol — Badalona, Barcelona, Spain

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment